From uncovering why young adults face rising cancer rates to pioneering vaccines and new therapies, MSK’s latest research is shaping the future of cancer care in the Middle East and worldwide.

DOHA, DUBAI, RIYADH. September 24, 2025. On World Cancer Research Day, Memorial Sloan Kettering Cancer Center (MSK) highlights pioneering research that is improving treatment options, expanding access to precision care, and offering hope to patients across the Middle East.

Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast U.S. and New York, Second in the Nation, and First for Urology Care by U.S. News & World Report

Middle East, 11August 2025:Memorial Sloan Kettering Cancer Center (MSK), a global leader in cancer care and research, has been recognized as the best cancer center in the Northeast United States and New York, the number two hospital for cancer care in the United States, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing. MSK has ranked as one of the top two cancer hospitals in the U.S. and the best cancer center in New York since these rankings were established more than 35 years ago., underscoring its longstanding commitment to excellence and innovation in cancer treatment.